Indena Chamomile Phytosome®
A trademarked form of Apigenin
Pharma-grade chamomile extract from Matricaria chamomilla flowers, formulated as a Phytosome® for enhanced bioavailability of apigenin and related flavonoids.
Manufacturer
Indena S.p.A.
Clinical Studies
0
Certifications
2
Purity
Standardised to apigenin content; pharmaceutical-grade
Last reviewed: 2024-05-01
What Makes It Different
Phytosome® phospholipid-complex technology improves oral absorption of the apigenin fraction relative to standard chamomile extracts.
Technical Specifications
Ingredient Type
Chamomile extract standardised to apigenin, complexed with phosphatidylcholine
Purity / Standardisation
Standardised to apigenin content; pharmaceutical-grade
Brand Owner
Indena S.p.A.
Country of Origin
Italy
Claims & Positioning
Enhanced oral bioavailability via Phytosome®
Pharmaceutical-grade standardisation
Frequently Asked Questions
What is Indena Chamomile Phytosome?
Indena Chamomile Phytosome® is a trademarked form of Apigenin manufactured by Indena S.p.A.. Pharma-grade chamomile extract from Matricaria chamomilla flowers, formulated as a Phytosome® for enhanced bioavailability of apigenin and related flavonoids.
How is Indena Chamomile Phytosome different from generic Apigenin?
Phytosome® phospholipid-complex technology improves oral absorption of the apigenin fraction relative to standard chamomile extracts.
Who makes Indena Chamomile Phytosome?
Indena Chamomile Phytosome is made by Indena S.p.A. (Italy).
How much clinical evidence does Indena Chamomile Phytosome have?
SuppIndex lists 0 clinical studies for Indena Chamomile Phytosome and 2 certifications (cGMP, Kosher). The parent ingredient Apigenin has an overall evidence score of 42/100 (Limited).
Parent Ingredient
Apigenin
A dietary flavone (C15H10O5, MW 270.24) acting as a partial agonist at the benzodiazepine site of GABA-A receptors (Ki ~4 µM), a competitive CD38 inhibitor (IC50 ~7–10 µM), an aromatase/CYP19A1 inhibitor (IC50 ~2.7 µM), and an Nrf2 activator / NF-κB suppressor. Oral bioavailability is poor (~5–10%) with plasma Cmax of 0.2–0.4 µM after dietary intake.
View the parent ingredient page for full evidence review, dosage guidance, mechanism of action, and safety information.
Products Using Indena Chamomile Phytosome®
Common Brands
Manufacturer
Indena S.p.A.
Italy
Certifications (2)
Goal Relevance
Compare
See how Indena Chamomile Phytosome® compares to other forms or the generic version.
Open Comparison